AMCA believes this information includes personal information, including certain financial data, Social Security numbers, and medical information, but not laboratory test results.ĪMCA has not yet provided Quest or Optum360 detailed or complete information about the AMCA data security incident, including which information of which individuals may have been affected.
Quest and Optum360 are working with forensic experts to investigate the matter.ĪMCA first notified Quest and Optum360 on of potential unauthorized activity on AMCA’s web payment page. On May 31, 2019, AMCA notified Quest and Optum360 that the data on AMCA’s affected system included information regarding approximately 11.9 million Quest patients. AMCA provides billing collections services to Optum360, which in turn is a Quest contractor. , J- American Medical Collection Agency (AMCA), a billing collections service provider, has informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest. To read this article on click here.SECAUCUS, N.J. McKesson Corporation (MCK) : Free Stock Analysis ReportĪMN Healthcare Services Inc (AMN) : Free Stock Analysis Report Quest Diagnostics Incorporated (DGX) : Free Stock Analysis Report Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. MCK has gained 46.4% against the industry’s 13.3% fall. McKesson has outperformed its industry in the past year. It currently carries a Zacks Rank #2 (Buy). The company surpassed earnings estimates in the trailing three quarters and missed in one, delivering a surprise of 13%, on average. McKesson has an estimated long-term growth rate of 9.9%. SWAV has gained 63.8% against the industry’s 32.3% fall over the past year. ShockWave Medical has outperformed its industry in the past year. The company’s earnings surpassed estimates in all the trailing four quarters, the average beat being 180.1%. ShockWave Medical, sporting a Zacks Rank #1 at present, has an estimated growth rate of 33.1% for 2023. AMN has lost 17.4% compared with the industry’s 30.7% fall. You can see the complete list of today’s Zacks #1 Rank stocks here.ĪMN Healthcare has outperformed its industry in the past year. It currently sports a Zacks Rank #1 (Strong Buy). The company surpassed earnings estimates in the trailing four quarters, delivering a surprise of 15.7%, on average.
SWAV and McKesson Corporation MCK.ĪMN Healthcare has a long-term earnings growth rate of 3.2%. Quest Diagnostics currently carries a Zacks Rank #3 (Hold).Ī few better-ranked stocks in the broader medical space that investors can consider are AMN Healthcare Services, Inc. The stock has lost 19.4% compared with a 37.6% decline of the industry.
In the past year, Quest Diagnostics has outperformed its industry. The base business testing category saw robust growth from testosterone, comprehensive metabolic panels and Lyme disease in the second quarter. In Q2, Quest Diagnostics delivered growth in direct-to-consumer testing, banking on its COVID-19 offerings and base business testing. The company introduced Quest AD-Detect, a blood test, to help in the early determination of Alzheimer’s disease. In the second quarter, the company saw robust performances in hematology, prenatal genetics and pharma services. Quest Diagnostics continues to ramp up investments in advanced diagnostics capabilities. Story continues Focus on Testing Expansion
0 kommentar(er)
